Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations

NCT03404817 is registered in ClinicalTrials.gov with Embera NeuroTherapeutics, Inc. as lead sponsor.

NCT NCT03404817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03404817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Crossover Comparative Bioavailability and Food Effect Study of Two EMB-001 Formulations
Lead sponsor
Embera NeuroTherapeutics, Inc.
Phase
Phase 1
Overall status
Completed
Start date
March 1, 2018
Completion date
June 7, 2018
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine use disorder